Ondansetron attenuates the activity of excitatory amino acid transporter type 3 expressed in Xenopus oocytes
- Authors
- Hur, Wonseok; Lee, Mi Kyoung; Park, Hee-Pyeong; Kim, Chong-Sung; Yoon, Hea-Jo; Zuo, Zhiyi; Do, Sang-Hwan
- Issue Date
- 15-6월-2014
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- EAAT3; Glutamate transporter; Ondansetron; Phosphatidylinositol 3-kinase; Protein kinase C; Xenupus oocyte
- Citation
- EUROPEAN JOURNAL OF PHARMACOLOGY, v.733, pp.7 - 12
- Indexed
- SCIE
SCOPUS
- Journal Title
- EUROPEAN JOURNAL OF PHARMACOLOGY
- Volume
- 733
- Start Page
- 7
- End Page
- 12
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/98231
- DOI
- 10.1016/j.ejphar.2014.03.027
- ISSN
- 0014-2999
- Abstract
- The purpose of this study was to evaluate the effect of ondansetron on excitatory amino acid transporter type 3 (EAAT3) and to elucidate the roles of protein kinase C (PKC) and phosphatidylinositol 3-kinase (PI3K) in the effect. EAAT3 was expressed in Xenopus oocytes following the injection of rat EAAT3 mRNAs. Using the two-electrode voltage clamping method, the inward currents induced by L-glutamate were measured for 1 min in the presence and absence of ondansetron (1-1000 mu M). Different concentrations of L-glutamate (3-300 mu M) were used to determine the kinetic characteristics of EAAT3. To identify the involvement. of PKC and PI3K in the effect, oocytes were exposed to a PKC activator and to PKC inhibitors and PI3K inhibitors, and L-glutamate-induced currents were recorded. Ondansetron decreased EAAT3 activity in a dose dependent manner in a kinetic study, ondansetron (10 mu M for 3 min) reduced V,but not K-m compared with the control group. The PKC activator abolished the ondansetron-induced decrease in EAAT3 activity. The PKC inhibitors (staurosporine and chelerythrine) and ondansetron had not additive or synergistic effects on EAAT3 activity. The PI3K( inhibitors (wortmannin and LY294002) decreased the EAAT3 response, although there were no differences among the groups comprising ondansetron, PI3K inhibitors, and PI3K inhibitors plus ondansetron. Our results demonstrate that ondansetron attenuates EAAT3 activity and this effect seems to be mediated by PKC and PI3K. (C) 2014 Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholar.korea.ac.kr/handle/2021.sw.korea/98231)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.